DOXILEK 500mg capsules medication leaflet

C05BX01 calcium dobesilate • Cardiovascular system | Antivaricose therapy | Other sclerosing agents

Calcii dobesilas is a medication used for the treatment of vascular conditions such as chronic venous insufficiency, hemorrhoids, and diabetic retinopathy. It has vasoprotective and anti-inflammatory properties, reducing capillary permeability and improving microcirculation.

The medication is taken orally, usually two or three times a day, as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the condition and the patient's response.

Common side effects include nausea, diarrhea, abdominal pain, and mild allergic reactions. In rare cases, more severe adverse effects such as severe skin rashes or liver disorders may occur.

Calcii dobesilas is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to adhere to the prescribed dosage to prevent adverse effects.

General data about DOXILEK 500mg

Substance: calcium dobesilate

Date of last drug list: 01-05-2026

Commercial code: W00727001

Concentration: 500mg

Pharmaceutical form: capsules

Quantity: 30

Product type: generic

Price: 43.97 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: LEK PHARMACEUTICALS D.D. - SLOVENIA

Holder: LEK PHARMACEUTICALS D.D. - SLOVENIA

Number: 13731/2021/01

Shelf life: 5 years

Compensation lists for DOXILEK 500mg Lek Pharmatech

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

43.97 RON

43.97 RON

0.00 RON